CpG ODNs, or CpG oligodeoxynucleotides, are short synthetic DNA molecules that contain unmethylated CpG motifs. These CpG motifs are specific DNA sequences that can stimulate the immune system by activating Toll-like receptor 9 (TLR9) present on immune cells. CpG ODNs have shown potential applications in immunotherapy and vaccine development.
Potential therapeutic uses of CpG oligodeoxynucleotides (DM Klinman, et al.,2004)
When CpG ODNs are introduced into the body, they can mimic the presence of bacterial or viral DNA, triggering an immune response. This immune activation can lead to enhanced production of cytokines, activation of antigen-presenting cells, and the generation of specific immune responses. CpG ODNs have been studied for their ability to stimulate both innate and adaptive immune responses, making them valuable tools in various research fields.
Our company offers a specialized service called Custom CpG ODNs Synthesis, where we provide tailored solutions for the synthesis of CpG ODNs according to the specific requirements of our clients. We have a team of experts who are experienced in CpG ODNs synthesis and are dedicated to delivering high-quality CpG ODNs that can contribute to research and development endeavors.
Our Custom CpG ODNs Synthesis service follows a streamlined process to ensure efficient and accurate delivery:
If you have any further questions or need more information about CpG ODNs or our Custom CpG ODNs Synthesis service, please don't hesitate to reach out to us. We are committed to providing exceptional customer service and assisting you with your CpG ODNs needs.
Toll-like receptors (TLRs) have been implicated in myocardial ischemia/reperfusion (I/R) injury. The TLR9 ligand, CpG-ODN has been reported to improve cell survival. We examined effect of CpG-ODN on myocardial I/R injury. Methods: Male C57BL/6 mice were treated with either CpG-ODN, control-ODN, or inhibitory CpG-ODN (iCpG-ODN) 1 h prior to myocardial ischemia (60 min) followed by reperfusion. Untreated mice served as I/R control (n=10/each group). Infarct size was determined by TTC straining. Cardiac function was examined by echocardiography before and after myocardial I/R up to 14 days. Results: CpG-ODN administration significantly decreased infarct size by 31.4% and improved cardiac function after myocardial I/R up to 14 days. Neither control-ODN nor iCpG-ODN altered I/R-induced myocardial infarction and cardiac dysfunction. CpG-ODN attenuated I/R-induced myocardial apoptosis and prevented I/R-induced decrease in Bcl2 and increase in Bax levels in the myocardium. CpG-ODN increased Akt and GSK-3β phosphorylation in the myocardium. In vitro data suggested that CpG-ODN treatment induced TLR9 tyrosine phosphorylation and promoted an association between TLR9 and the p85 subunit of PI3K. Importantly, PI3K/Akt inhibition and Akt kinase deficiency abolished CpG-ODN-induced cardioprotection. Conclusion: CpG-ODN, the TLR9 ligand, induces protection against myocardial I/R injury. The mechanisms involve activation of the PI3K/Akt signaling pathway.
CpG-ODN administration attenuated I/R-increased myocardial apoptosis(Z Cao, et al.,2013)
Here are some frequently asked questions about our Custom CpG ODNs Synthesis service:
A: The time required for synthesis can vary depending on the length and complexity of the CpG ODNs sequence. During the consultation phase, we will provide you with an estimated timeline based on your specific requirements. We strive to deliver synthesized CpG ODNs within a reasonable timeframe without compromising on quality.
A: Yes, we have the capability to incorporate modified nucleotides into the CpG ODNs synthesis process. Please let us know your specific requirements during the consultation. Our team of experts will work with you to design and synthesize CpG ODNs with the desired modifications to meet your research needs.
A: We understand that research needs can vary, and we accommodate both small and large-scale orders. Whether you require a small quantity for pilot studies or a larger quantity for extensive research projects, we are here to assist you. Please contact us with your requirements, and we will provide you with the necessary information and support.
A: Yes, our Custom CpG ODNs Synthesis service can provide CpG ODNs that are compatible with various immunotherapy approaches. Whether you are working on cancer immunotherapy, infectious diseases, or other immunotherapeutic applications, our experts can design and synthesize CpG ODNs tailored to your specific needs.
A: Absolutely! Along with the delivery of the synthesized CpG ODNs, we provide comprehensive documentation that includes sequence information, quality control data, and storage recommendations. Additionally, our team of experts is available to offer technical support and address any questions or concerns you may have regarding the CpG ODNs.
A: Yes, we offer competitive pricing for large-scale orders of Custom CpG ODNs Synthesis. Our team will work closely with you to understand your requirements and provide a customized quote that takes into account the quantity and specifications of the CpG ODNs you need.
A: Absolutely! We understand that different research applications may require specific purity levels for CpG ODNs. Our synthesis process can be tailored to meet your purification requirements, ensuring that you receive CpG ODNs of the desired purity for your research and development needs.
A: We offer various shipping options to accommodate your needs. Whether you require standard shipping or expedited delivery, we can work with you to arrange the most suitable shipping method. Please let us know your preferences during the consultation, and we will provide you with the available options.
If you have any further questions or need more information, please don't hesitate to reach out to us. Our team is dedicated to providing exceptional customer service and assisting you with your Custom CpG ODNs Synthesis needs.
If you have any further questions or need more information, please don't hesitate to reach out to us. Our team is dedicated to providing exceptional customer service and assisting you with your Custom CpG ODNs Synthesis needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.